+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Veterinary Drug Market by Drug Type (Anti-Infective, Anti-Inflammatory, Parasiticide), Animal Type (Companion Animal, Livestock Animal), Route of Administration - Forecast 2023-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2023
  • Region: Global
  • 360iResearch™
  • ID: 4986087
UP TO OFF until Dec 31st 2023
1h Free Analyst Time

Quick Summary:

In the dynamic landscape of animal healthcare, the Veterinary Drug Market stands as a cornerstone for advancing the well-being of both companion and livestock animals. As a senior executive, you understand the necessity of staying abreast with market trends and making informed decisions that spearhead your company's strategic positioning. Navigating through the intricacies of this market warrants a meticulous and comprehensive research report that underscores not only growth trajectories but also the nuanced shifts across various sub-markets.

The depth of analysis provided in this report encapsulates pivotal information from drug types to routes of administration, charting out a panorama of the Veterinary Drug Market. With a keen emphasis on drug categories such as Anti-Infective and Parasiticide, along with detailed examinations of animal and regional segments, it illuminates areas ripe for market penetration and development. This report is an essential compass for steering through market diversification and understanding the competitive landscape shaped by key vendors.

Armed with insights from our comprehensive analysis, you will be equipped to make data-driven decisions that leverage market opportunities, embrace product innovation, and refine your competitive strategy. This indispensable intelligence not only answers pressing questions regarding market size and forecasts but also provides a strategic edge for your business in the Veterinary Drug Market.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Veterinary Drug Market size was estimated at USD 21.76 billion in 2022, USD 23.03 billion in 2023, growing at a CAGR of 5.96% to reach USD 34.60 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Veterinary Drug Market.
  • Based on Drug Type, the market is studied across Anti-Infective, Anti-Inflammatory, and Parasiticide. The Anti-Infective is projected to witness significant market share during forecast period.
  • Based on Animal Type, the market is studied across Companion Animal and Livestock Animal. The Livestock Animal is projected to witness significant market share during forecast period.
  • Based on Route of Administration, the market is studied across Oral, Parenteral, and Topical. The Parenteral is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Veterinary Drug Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Veterinary Drug Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Veterinary Drug Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Veterinary Drug Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Veterinary Drug Market?
  3. What is the competitive strategic window for identifying opportunities in the Veterinary Drug Market?
  4. What are the latest technology trends and regulatory frameworks in the Veterinary Drug Market?
  5. What is the market share of the leading vendors in the Veterinary Drug Market?
  6. Which modes and strategic moves are suitable for entering the Veterinary Drug Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Frequently Asked Questions about the Global Veterinary Drug Market

What is the estimated value of the Global Veterinary Drug Market?

The Global Veterinary Drug Market was estimated to be valued at $23.03 Billion in 2023.

What is the growth rate of the Global Veterinary Drug Market?

The growth rate of the Global Veterinary Drug Market is 5.9%, with an estimated value of $34.6 Billion by 2030.

What is the forecasted size of the Global Veterinary Drug Market?

The Global Veterinary Drug Market is estimated to be worth $34.6 Billion by 2030.

Who are the key companies in the Global Veterinary Drug Market?

Key companies in the Global Veterinary Drug Market include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc. and Neogen Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary Drug Market, by Drug Type, 2022 vs 2030
4.3. Veterinary Drug Market, by Animal Type, 2022 vs 2030
4.4. Veterinary Drug Market, by Route of Administration, 2022 vs 2030
4.5. Veterinary Drug Market, by Region, 2022 vs 2030
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing pet ownership and livestock population in economies
5.1.1.2. Growing penetration of pet insurance
5.1.1.3. Growing availability of numerous veterinary drugs for treatment of several diseases
5.1.2. Restraints
5.1.2.1. High pet care cost
5.1.3. Opportunities
5.1.3.1. Introduction of new and advanced veterinary drugs
5.1.3.2. Expansion of animal healthcare expenditure
5.1.4. Challenges
5.1.4.1. Complexities associated with the production
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
6. Veterinary Drug Market, by Drug Type
6.1. Introduction
6.2. Anti-Infective
6.3. Anti-Inflammatory
6.4. Parasiticide
7. Veterinary Drug Market, by Animal Type
7.1. Introduction
7.2. Companion Animal
7.3. Livestock Animal
8. Veterinary Drug Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical
9. Americas Veterinary Drug Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Veterinary Drug Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Veterinary Drug Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Biogenesis Bago SA
13.1.2. Boehringer Ingelheim International GmbH
13.1.3. Ceva Sante Animale
13.1.4. Dechra Pharmaceuticals PLC
13.1.5. Elanco Animal Health Incorporated
13.1.6. Evonik Industries AG
13.1.7. Hester Biosciences Limited
13.1.8. Huvepharma, Inc.
13.1.9. Merck & Co., Inc.
13.1.10. Neogen Corporation
13.1.11. Nutreco N.V.
13.1.12. Perrigo Company PLC
13.1.13. Vetoquinol S.A.
13.1.14. Virbac S.A.
13.1.15. Zoetis Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. VETERINARY DRUG MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY DRUG MARKET SIZE, 2022 VS 2030
FIGURE 3. VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
FIGURE 5. VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2030 (%)
FIGURE 6. VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 7. VETERINARY DRUG MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. VETERINARY DRUG MARKET DYNAMICS
FIGURE 9. VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 5. VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VETERINARY DRUG MARKET SIZE, BY PARASITICIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 9. VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 12. VETERINARY DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VETERINARY DRUG MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VETERINARY DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. CANADA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. MEXICO VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. CHINA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 44. CHINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. INDIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. INDIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. JAPAN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. THAILAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. DENMARK VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 81. DENMARK VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. EGYPT VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. FINLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. GERMANY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. ITALY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. NORWAY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. POLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. POLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. QATAR VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. QATAR VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. TURKEY VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 143. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2022
TABLE 144. VETERINARY DRUG MARKET LICENSE & PRICING

Companies Mentioned

  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nutreco N.V.
  • Perrigo Company PLC
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...